Te Liu Selected Research

Drug Therapy (Chemotherapy)

1/2024	Construction and validation of molecular subtype and signature of immune cell-related telomeric genes and prediction of prognosis and immunotherapy efficacy in ovarian cancer patients.
4/2016	Long non-coding RNA BACE1-AS is a novel target for anisomycin-mediated suppression of ovarian cancer stem cell proliferation and invasion.
12/2013	Induction of estrogen-sensitive epithelial cells derived from human-induced pluripotent stem cells to repair ovarian function in a chemotherapy-induced mouse model of premature ovarian failure.
1/2012	CD44+/CD105+ human amniotic fluid mesenchymal stem cells survive and proliferate in the ovary long-term in a mouse model of chemotherapy-induced premature ovarian failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Te Liu Research Topics

Disease

32	Neoplasms (Cancer) 04/2024 - 12/2009
15	Primary Ovarian Insufficiency 01/2023 - 01/2012
13	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 12/2009
11	Parkinson Disease (Parkinson's Disease) 06/2023 - 02/2012
10	Atherosclerosis 01/2022 - 06/2013
9	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 01/2021
8	Inflammation (Inflammations) 06/2023 - 10/2017
6	Alzheimer Disease (Alzheimer's Disease) 06/2023 - 12/2013
6	Macular Degeneration (Age-Related Maculopathy) 03/2023 - 01/2017
6	Body Weight (Weight, Body) 01/2022 - 07/2014
5	Carcinogenesis 07/2023 - 10/2017
4	Mitochondrial Diseases (Mitochondrial Disease) 12/2023 - 09/2014
4	Neoplasm Metastasis (Metastasis) 01/2023 - 05/2014
4	Glioblastoma (Glioblastoma Multiforme) 12/2022 - 08/2016
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 04/2024 - 05/2021
3	Infections 01/2023 - 07/2015
3	Precocious Puberty 04/2022 - 08/2018
3	Endometrial Neoplasms (Endometrial Cancer) 01/2019 - 10/2011
2	Lung Neoplasms (Lung Cancer) 01/2024 - 09/2011
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2023 - 01/2021
2	Cognitive Dysfunction 05/2023 - 01/2018
2	Obesity 03/2023 - 11/2016
2	Fibrosis (Cirrhosis) 01/2023 - 01/2021
2	Kidney Neoplasms (Kidney Cancer) 01/2023 - 01/2019
2	Pre-Eclampsia (Preeclampsia) 09/2022 - 03/2011
2	Proteinuria 09/2022 - 01/2019
2	Hemorrhoids 02/2021 - 07/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 12/2018
2	Glioma (Gliomas) 01/2020 - 08/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 10/2017
2	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 08/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 01/2015
1	Alopecia (Baldness) 09/2024
1	Experimental Arthritis 04/2024
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2023

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 02/2024 - 08/2011
16	MicroRNAs (MicroRNA)IBA 01/2023 - 09/2011
10	Messenger RNA (mRNA)IBA 01/2023 - 07/2014
10	Diethylhexyl Phthalate (DEHP)IBA 04/2022 - 07/2014
8	Amyloid (Amyloid Fibrils)IBA 05/2023 - 12/2013
7	Long Noncoding RNAIBA 04/2024 - 09/2014
7	AnisomycinIBA 07/2023 - 04/2016
5	Therapeutic UsesIBA 01/2024 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2018
4	CytokinesIBA 06/2023 - 10/2017
4	polydopamineIBA 01/2023 - 01/2020
4	LipidsIBA 12/2019 - 11/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2024 - 09/2016
3	TubulinIBA 10/2023 - 10/2021
3	Antineoplastic Agents (Antineoplastics)IBA 10/2023 - 01/2020
3	CateninsIBA 07/2023 - 01/2022
3	Circular RNAIBA 06/2023 - 01/2021
3	ThymopentinIBA 06/2023 - 01/2021
3	6-methyladenineIBA 03/2023 - 02/2021
3	Neuroprotective AgentsIBA 01/2023 - 08/2015
3	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2021
3	Hormones (Hormone)IBA 01/2022 - 01/2018
3	Sirtuin 1IBA 01/2021 - 08/2015
3	fisetinIBA 01/2020 - 01/2019
3	oxidized low density lipoproteinIBA 01/2020 - 07/2018
2	SteroidsIBA 04/2024 - 05/2021
2	AntioxidantsIBA 04/2024 - 01/2020
2	Cyclin D1IBA 11/2023 - 07/2015
2	Adenosine Triphosphate (ATP)IBA 10/2023 - 12/2022
2	Small Interfering RNA (siRNA)IBA 07/2023 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2023 - 01/2023
2	N-methyladenosineIBA 03/2023 - 01/2023
2	Glutathione (Reduced Glutathione)IBA 01/2023 - 12/2022
2	Immunoglobulin A (IgA)IBA 01/2023 - 01/2019
2	Retinal Pigments (Pigments, Visual)IBA 01/2023 - 01/2020
2	PyrrolesIBA 12/2022 - 10/2021
2	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022 - 01/2020
2	Finasteride (Propecia)FDA LinkGeneric 01/2022 - 01/2020
2	Imatinib Mesylate (Gleevec)FDA Link 10/2021 - 01/2020
2	SugarsIBA 08/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 01/2020
2	EnzymesIBA 01/2021 - 08/2015
2	Polysaccharides (Glycans)IBA 01/2020 - 01/2019
2	Insulin (Novolin)FDA Link 02/2018 - 11/2016
2	LeptinIBA 02/2018 - 11/2016
2	CurcuminIBA 01/2018 - 10/2017
2	InterleukinsIBA 01/2018 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2016
2	Amyloid beta-PeptidesIBA 10/2017 - 01/2017
2	Competitive Endogenous RNAIBA 10/2017 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2015 - 05/2014
1	ginsenoside Rh2IBA 04/2024
1	FlavonoidsIBA 01/2024
1	16S Ribosomal RNAIBA 01/2024
1	kaempferolIBA 01/2024
1	Ribosomal DNA (rDNA)IBA 01/2024
1	ElementsIBA 12/2023
1	Carrier Proteins (Binding Protein)IBA 12/2023

Therapy/Procedure

8	Therapeutics 01/2024 - 01/2016
5	Transplantation 01/2023 - 02/2012
4	Drug Therapy (Chemotherapy) 01/2024 - 01/2012
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2016
2	Electroacupuncture 01/2023 - 01/2022
1	Immunotherapy 01/2024